Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699

Mansi Verma; Jaspreet Kaur; Mukesh Kumar; Kirti Kumari; Anjali Saxena; Shailly Anand; Aeshna Nigam; Vydianathan Ravi; Saurabh Raghuvanshi; Paramjit Khurana; Akhilesh K Tyagi; Jitendra P Khurana; Rup Lal

doi:10.1128/JB.05819-11

Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699

J Bacteriol. 2011 Oct;193(19):5562-3. doi: 10.1128/JB.05819-11.

Authors

Mansi Verma¹, Jaspreet Kaur, Mukesh Kumar, Kirti Kumari, Anjali Saxena, Shailly Anand, Aeshna Nigam, Vydianathan Ravi, Saurabh Raghuvanshi, Paramjit Khurana, Akhilesh K Tyagi, Jitendra P Khurana, Rup Lal

Affiliation

¹ Department of Zoology, University of Delhi, Delhi 110 007, India.

Abstract

Amycolatopsis mediterranei S699 is an actinomycete that produces an important antibiotic, rifamycin B. Semisynthetic derivatives of rifamycin B are used for the treatment of tuberculosis, leprosy, and AIDS-related mycobacterial infections. Here, we report the complete genome sequence (10.2 Mb) of A. mediterranei S699, with 9,575 predicted coding sequences.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Actinomycetales / genetics*
Actinomycetales / metabolism*
Anti-Bacterial Agents / biosynthesis*
Genome, Bacterial / genetics*
Molecular Sequence Data
Rifamycins / biosynthesis*

Substances

Anti-Bacterial Agents
Rifamycins
rifamycin B

Associated data

GENBANK/CP002896